Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, HSCs, antibodies, viral, bioengineering, Diseases, Therapies, GVHD, cell regulation, Pediatric, Biological Processes, white blood cells, Technology and Procedures, cell expansion, Immune Disorders, immune cells, epigenetics, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, transplantation, immune mechanism, flow cytometry, molecular testing, serologic tests, pathogenesis
	Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, HSCs, antibodies, viral, bioengineering, Diseases, Therapies, GVHD, cell regulation, Pediatric, Biological Processes, white blood cells, Technology and Procedures, cell expansion, Immune Disorders, immune cells, epigenetics, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, transplantation, immune mechanism, flow cytometry, molecular testing, serologic tests, pathogenesis
Sunday, December 6, 2020: 12:00 PM-1:30 PM
	
	
	
	
	   
			
		Moderators:
			
				
				
					
						
						
						
							Brian G. Engelhardt, MD, Vanderbilt University Medical Center
						
					
					
				
					
						 and 
						
						
							Joseph Pidala, MD, H. Lee Moffitt Cancer Center and Research Institute
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Pidala: Syndax: Consultancy, Membership on an entity's Board of Directors or advisory committees; CTI Biopharma: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Amgen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Novartis: Research Funding; Takeda: Research Funding; Janssen: Research Funding; Johnson and Johnson: Research Funding; Pharmacyclics: Research Funding; Abbvie: Research Funding; BMS: Research Funding. 
			 
		12:00 PM
	
	
12:15 PM
	
	
12:45 PM
	
	
1:00 PM
	
	
1:15 PM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					
 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.